Process View
The process in which an organism effects a change in the structure or processes of a second organism, where the two organisms are in a symbiotic interaction.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "modification of morphology or physiology of other organism involved in symbiotic interaction"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| SP1 | Sp1 transcription factor | 0.868 | ||
| SMAD3 | SMAD family member 3 | 0.776 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.759 | Human | |
| JUN | jun proto-oncogene | 0.745 | ||
| IL8 | interleukin 8 | 0.742 | ||
| BCL2L1 | BCL2-like 1 | 0.741 | ||
| RARA | retinoic acid receptor, alpha | 0.691 | ||
| SMAD2 | SMAD family member 2 | 0.645 | Human | |
| CCR5 | chemokine (C-C motif) receptor 5 | 0.504 | ||
| ARID1B | AT rich interactive domain 1B (SWI1-like) | 0.360 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.298 | Mouse | |
| RRAGC | Ras-related GTP binding C | 0.293 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.265 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.227 | Mouse | |
| RPS6KA5 | ribosomal protein S6 kinase, 90kDa, polypeptide 5 | 0.201 | ||
| BAX | BCL2-associated X protein | 0.182 | Human | |
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.168 | Mouse | |
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.166 | Mouse | |
| SMAD7 | SMAD family member 7 | 0.143 | Human | |
| SMAD4 | SMAD family member 4 | 0.137 | Human | |
| EP300 | E1A binding protein p300 | 0.120 | ||
| KDM6A | lysine (K)-specific demethylase 6A | 0.118 | ||
| SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.104 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.102 | Human | |
| ATF3 | activating transcription factor 3 | 0.101 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.096 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.095 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.093 | Human | |
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.081 | ||
| UTRN | utrophin | 0.079 | ||
| SOX10 | SRY (sex determining region Y)-box 10 | 0.077 | ||
| FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.077 | ||
| PAX3 | paired box 3 | 0.076 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.075 | ||
| IL1B | interleukin 1, beta | 0.070 | ||
| SMAD1 | SMAD family member 1 | 0.068 | Human | |
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.068 | ||
| SMAD5 | SMAD family member 5 | 0.067 | Human | |
| IL6 | interleukin 6 (interferon, beta 2) | 0.067 | ||
| SKIL | SKI-like oncogene | 0.065 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.065 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.063 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.063 | Mouse | |
| NCOA1 | nuclear receptor coactivator 1 | 0.061 | ||
| FOXD3 | forkhead box D3 | 0.060 | ||
| GABPA | GA binding protein transcription factor, alpha subunit 60kDa | 0.060 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.057 | ||
| DMD | dystrophin | 0.056 | ||
| CREBBP | CREB binding protein | 0.055 | Human | |
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.054 | Human | |
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.054 | ||
| SOX2 | SRY (sex determining region Y)-box 2 | 0.053 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.052 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.050 | Human | |
| WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.050 | ||
| PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.049 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.048 | ||
| HDAC1 | histone deacetylase 1 | 0.042 | ||
| HMGA1 | high mobility group AT-hook 1 | 0.041 | Human | |
| CCL22 | chemokine (C-C motif) ligand 22 | 0.040 | Human | |
| CCL13 | chemokine (C-C motif) ligand 13 | 0.040 | Human | |
| HIPK2 | homeodomain interacting protein kinase 2 | 0.040 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.040 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.039 | ||
| ESR1 | estrogen receptor 1 | 0.039 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.038 | Human | |
| RBBP4 | retinoblastoma binding protein 4 | 0.038 | ||
| LAMTOR1 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 | 0.037 | ||
| BAD | BCL2-associated agonist of cell death | 0.035 | ||
| TNF | tumor necrosis factor | 0.033 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.032 | Human | |
| CCL20 | chemokine (C-C motif) ligand 20 | 0.032 | Human | |
| BID | BH3 interacting domain death agonist | 0.032 | ||
| SMARCC1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 | 0.032 | ||
| OCIAD1 | OCIA domain containing 1 | 0.031 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.031 | ||
| ATF2 | activating transcription factor 2 | 0.031 | Human | |
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.031 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.029 | Human | |
| FAM46A | family with sequence similarity 46, member A | 0.029 | ||
| DDX58 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | 0.029 | ||
| RNF11 | ring finger protein 11 | 0.029 | ||
| TBP | TATA box binding protein | 0.028 | ||
| RRAGD | Ras-related GTP binding D | 0.028 | ||
| ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.027 | ||
| RAB6A | RAB6A, member RAS oncogene family | 0.027 | ||
| MAGEB18 | melanoma antigen family B, 18 | 0.027 | ||
| PROX1 | prospero homeobox 1 | 0.026 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.026 | ||
| SMARCD1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | 0.026 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.025 | ||
| KCTD17 | potassium channel tetramerisation domain containing 17 | 0.025 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.025 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.025 | Rat | |
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.025 | ||
| ENG | endoglin | 0.024 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.024 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.024 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.024 | ||
| RNR2 | l-rRNA | 0.023 | ||
| SREBF2 | sterol regulatory element binding transcription factor 2 | 0.023 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.023 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.023 | ||
| TP53 | tumor protein p53 | 0.023 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.023 | ||
| ADAMTSL4 | ADAMTS-like 4 | 0.023 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.022 | ||
| IER2 | immediate early response 2 | 0.022 | ||
| MED25 | mediator complex subunit 25 | 0.022 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.021 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.021 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.021 | Human | |
| EGR1 | early growth response 1 | 0.021 | ||
| TLE1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) | 0.020 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.020 | ||
| IFNG | interferon, gamma | 0.020 | ||
| INSR | insulin receptor | 0.020 | ||
| DTNA | dystrobrevin, alpha | 0.019 | ||
| SIRT1 | sirtuin 1 | 0.019 | ||
| APOA2 | apolipoprotein A-II | 0.019 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.019 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.019 | ||
| USP9Y | ubiquitin specific peptidase 9, Y-linked | 0.018 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.018 | Human | |
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.018 | ||
| SP3 | Sp3 transcription factor | 0.018 | Human | |
| CH25H | cholesterol 25-hydroxylase | 0.017 | ||
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.017 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.017 | ||
| UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.017 | ||
| CD83 | CD83 molecule | 0.017 | ||
| IL10 | interleukin 10 | 0.017 | ||
| FSTL1 | follistatin-like 1 | 0.017 | ||
| ARID1A | AT rich interactive domain 1A (SWI-like) | 0.017 | ||
| IL1A | interleukin 1, alpha | 0.017 | ||
| LAT | linker for activation of T cells | 0.017 | ||
| IDE | insulin-degrading enzyme | 0.017 | ||
| HCFC1 | host cell factor C1 (VP16-accessory protein) | 0.017 | ||
| APPL1 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 | 0.017 | ||
| RNF144B | ring finger protein 144B | 0.017 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.017 | ||
| TAF13 | TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa | 0.017 | ||
| ESRRG | estrogen-related receptor gamma | 0.017 | ||
| PPP2R2B | protein phosphatase 2, regulatory subunit B, beta | 0.017 | ||
| JDP2 | Jun dimerization protein 2 | 0.017 | ||
| SELE | selectin E | 0.016 | ||
| OSBPL9 | oxysterol binding protein-like 9 | 0.016 | ||
| YY1 | YY1 transcription factor | 0.016 | ||
| F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 0.016 | ||
| JUNB | jun B proto-oncogene | 0.016 | Human | |
| DUSP3 | dual specificity phosphatase 3 | 0.016 | ||
| HIC1 | hypermethylated in cancer 1 | 0.016 | ||
| RAB14 | RAB14, member RAS oncogene family | 0.016 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.016 | ||
| THBS1 | thrombospondin 1 | 0.016 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.016 | ||
| ING2 | inhibitor of growth family, member 2 | 0.016 | ||
| UBD | ubiquitin D | 0.016 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.015 | ||
| INADL | InaD-like (Drosophila) | 0.015 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.015 | ||
| TAF1 | TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa | 0.015 | ||
| BCL2A1 | BCL2-related protein A1 | 0.015 | ||
| ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.015 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.015 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.015 | ||
| NOTCH1 | notch 1 | 0.014 | ||
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.014 | ||
| ARRB1 | arrestin, beta 1 | 0.014 | ||
| VAPB | VAMP (vesicle-associated membrane protein)-associated protein B and C | 0.014 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.014 | ||
| FOSL1 | FOS-like antigen 1 | 0.014 | ||
| INHBA | inhibin, beta A | 0.014 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.014 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.014 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.014 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.014 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.014 | ||
| HNF1A | HNF1 homeobox A | 0.013 | ||
| RCOR1 | REST corepressor 1 | 0.013 | ||
| IL7R | interleukin 7 receptor | 0.013 | ||
| CCL1 | chemokine (C-C motif) ligand 1 | 0.013 | Human | |
| SMARCE1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 | 0.013 | ||
| GLTPD1 | glycolipid transfer protein domain containing 1 | 0.013 | ||
| FBXL15 | F-box and leucine-rich repeat protein 15 | 0.013 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.013 | ||
| BCL2L2 | BCL2-like 2 | 0.013 | Human | |
| NCOA2 | nuclear receptor coactivator 2 | 0.013 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.013 | ||
| TCF4 | transcription factor 4 | 0.013 | ||
| MAPK3 | mitogen-activated protein kinase 3 | 0.013 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.013 | ||
| TIAL1 | TIA1 cytotoxic granule-associated RNA binding protein-like 1 | 0.013 | ||
| APOC1 | apolipoprotein C-I | 0.013 | ||
| STAT5B | signal transducer and activator of transcription 5B | 0.013 | ||
| GHR | growth hormone receptor | 0.013 | ||
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.013 | ||
| ATF7IP | activating transcription factor 7 interacting protein | 0.013 | ||
| BBC3 | BCL2 binding component 3 | 0.013 | ||
| BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | 0.013 | ||
| NR1H2 | nuclear receptor subfamily 1, group H, member 2 | 0.013 | ||
| POU3F2 | POU class 3 homeobox 2 | 0.013 | Human | |
| NCOA6 | nuclear receptor coactivator 6 | 0.013 | ||
| BATF | basic leucine zipper transcription factor, ATF-like | 0.013 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.012 | ||
| ICOS | inducible T-cell co-stimulator | 0.012 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.012 | ||
| HRK | harakiri, BCL2 interacting protein (contains only BH3 domain) | 0.012 | ||
| IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.012 | ||
| STAU1 | staufen, RNA binding protein, homolog 1 (Drosophila) | 0.012 | ||
| PBRM1 | polybromo 1 | 0.012 | ||
| AR | androgen receptor | 0.012 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.012 | ||
| IL32 | interleukin 32 | 0.012 | ||
| MTA1 | metastasis associated 1 | 0.012 | ||
| MTA3 | metastasis associated 1 family, member 3 | 0.012 | ||
| RHOB | ras homolog gene family, member B | 0.012 | ||
| MECP2 | methyl CpG binding protein 2 (Rett syndrome) | 0.012 | ||
| NKG7 | natural killer cell group 7 sequence | 0.012 | ||
| CFB | complement factor B | 0.012 | ||
| TCF12 | transcription factor 12 | 0.012 | ||
| ARID2 | AT rich interactive domain 2 (ARID, RFX-like) | 0.012 | ||
| IL2RB | interleukin 2 receptor, beta | 0.012 | ||
| MEP1A | meprin A, alpha (PABA peptide hydrolase) | 0.012 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.012 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.012 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.012 | ||
| HAO1 | hydroxyacid oxidase (glycolate oxidase) 1 | 0.011 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.011 | ||
| GSTCD | glutathione S-transferase, C-terminal domain containing | 0.011 | ||
| PSEN1 | presenilin 1 | 0.011 | ||
| FPR3 | formyl peptide receptor 3 | 0.011 | ||
| IRF4 | interferon regulatory factor 4 | 0.011 | ||
| APOC3 | apolipoprotein C-III | 0.011 | ||
| IRF1 | interferon regulatory factor 1 | 0.011 | ||
| NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.011 | ||
| CITED1 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 | 0.011 | ||
| PTPN7 | protein tyrosine phosphatase, non-receptor type 7 | 0.011 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.011 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.011 | ||
| AZU1 | azurocidin 1 | 0.011 | ||
| CDCP1 | CUB domain containing protein 1 | 0.011 | ||
| DDX3Y | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked | 0.011 | ||
| GRIP1 | glutamate receptor interacting protein 1 | 0.011 | ||
| ZBED5 | zinc finger, BED-type containing 5 | 0.011 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.011 | ||
| CPN1 | carboxypeptidase N, polypeptide 1 | 0.011 | ||
| ACVR2B | activin A receptor, type IIB | 0.011 | ||
| DBN1 | drebrin 1 | 0.011 | ||
| KLF6 | Kruppel-like factor 6 | 0.011 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.010 | ||
| VAPA | VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa | 0.010 | Human | |
| EBI3 | Epstein-Barr virus induced 3 | 0.010 | ||
| CALR | calreticulin | 0.010 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.010 | ||
| RUNX3 | runt-related transcription factor 3 | 0.010 | ||
| SRSF11 | serine/arginine-rich splicing factor 11 | 0.010 | ||
| TNIK | TRAF2 and NCK interacting kinase | 0.010 | ||
| RWDD3 | RWD domain containing 3 | 0.010 | ||
| ACVR1B | activin A receptor, type IB | 0.010 | ||
| TFAP2A | transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | 0.010 | ||
| MPO | myeloperoxidase | 0.010 | ||
| TRIM9 | tripartite motif containing 9 | 0.010 | ||
| ELN | elastin | 0.010 | ||
| TBC1D17 | TBC1 domain family, member 17 | 0.010 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.010 | ||
| PRMT6 | protein arginine methyltransferase 6 | 0.010 | ||
| GOLGA1 | golgin A1 | 0.010 | ||
| APOC2 | apolipoprotein C-II | 0.010 | ||
| PGR | progesterone receptor | 0.010 | ||
| MTA2 | metastasis associated 1 family, member 2 | 0.010 | ||
| DCP1A | DCP1 decapping enzyme homolog A (S. cerevisiae) | 0.010 | ||
| HOXC8 | homeobox C8 | 0.010 | ||
| AQP9 | aquaporin 9 | 0.010 | ||
| MEOX2 | mesenchyme homeobox 2 | 0.010 |